|
Marín LA, Moya-Quiles MR, Miras M, Minguela A, Bermejo J, Ramírez P, García-Alonso AM, Parrilla P, Alvarez-López MR, Muro M. Evolution of soluble forms of CD86, CD95 and CD95L molecules in liver transplant recipients. Transpl Immunol. 2012 Mar;26(2-3):94-100. doi: 10.1016/j.trim.2011.12.001. Epub 2011 Dec 13. PubMed PMID: 22182632.
AÑO: 2012; IF: 1.52
|
22182632
|
Bosch A, Llorente S, Diaz JA, Salgado G, López M, Boix F, López-Hernández R, González-Soriano MJ, Campillo JA, Moya-Quiles MR, Perez-Lopez N, Minguela A, Jimeno L, Alvarez-López MR, Muro M. Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation. Hum Immunol. 2012 May;73(5):522-5. doi: 10.1016/j.humimm.2012.02.020. Epub 2012 Mar 6. PubMed PMID: 22425738.
AÑO: 2012; IF: 2.298
|
|
Muro M, Moya-Quiles MR, Marin L, Torío A, Vallejo C, Moraleda JM, Alvarez-López MR. Report of recombinations between HLA loci within two families: utility of high resolution typing. Clin Transplant. 2002 Oct;16(5):329-33. PubMed PMID: 12225428.
AÑO: 2002; IF: 1.534
|
|
Blanco-García RM, López-Álvarez MR, Garrido IP, Salgado-Cecilia G, Campillo JA, Bolarín JM, Gimeno L, Muro M, García-Alonso AM, Martínez-Sánchez MV, Bernardo Pisa MV, Soriano-Díaz S, Pascual-Figal DA, Alvarez-López MR, Minguela A. Post-transplant increase in soluble human leukocyte antigen-G associated with non-severe cardiac allograft vasculopathy. Hum Immunol. 2013 Mar;74(3):318-24. doi: 10.1016/j.humimm.2012.12.001. PubMed PMID: 23247208.
AÑO: 2013; IF: 2.282
|
|
San Segundo D, Brunet M, Ballesteros MA, Millán O, Muro M, Castro MJ, Miñambres E, López-Hoyos M. Prospective study of biomarkers of immune response in lung transplant recipients. Transplant Proc. 2012 Nov;44(9):2666-8. doi: 10.1016/j.transproceed.2012.09.082. PubMed PMID: 23146488.
AÑO: 2012; IF: 0.952
|